Tappe fondamentali della storia della Biohit
Year | Events | Net Sales EUR million |
2014 | New products: Calprotectin test for diagnosis and monitoring of inflammatory bowel diseases, Biohit Active B12 test to diagnosis of B12 vitamin deficiency | |
2013 | Subsidiary in Italy Joint Venture in China, Biohit Healthcare (Hefei) Co. Ltd. | 3.5 |
2012 | International patents, incl. US, China, Europatent | 2.0 |
2011 | Launch of the unique Acetium® capsule that reduces carcinogenic acetaldehyde in the stomach Establishment of a representative office in Singapore Semi Korpela appointed new President & CEO of Biohit Group | 2.2 |
2010 | Launch of the Acetium capsule that reduces carcinogenic acetaldehyde in anacidic stomach Establishment of a representative office in Singapore | 40.0 |
2009 | Establishement of Biohit subsidiary in India Launch of Pipetting Academy Launch of SafetySpace™ Filter Tips Renewal of product packages Accreditation of Biohit’s pipette calibration laboratory in Russia | 35.4 |
2008 | 20th Anniversary of Biohit Launch of ColonView faecal occult blood test Launch of new filter tips Accreditation of Biohit’s calibration laboratory in Germany | 35.1 |
2007 | Launch of the new Proline Plus mechanical pipette range Launch of GastroView (3-in-1 Indigestion Test) in the UK Agrrement with VWR concerning liquid handling product sales in Europe | 32.7 |
2006 | Liquid Handling business receives ISO 13485 certification (CE/IVD compliance) Biohit opens subsidiary and starts pipette assembly in China Launch of the electronic eLINE Dispenser for multiple dispensing Chinese scientists recommend GastroPanel for use in Chinese health care Biohit announces its new products that reduce carcinogenic acetaldehyde in the mouth and stomach Launch of the Helicobacter pylori IgA/IgG ELISA test | 31.4 |
2005 | China´s State Food and Drug Administration (SFDA) granted Biohit a marketing authorization for the Pepsinogen I & II and Gastrin-17 tests included in the GastroPanel examination New contracts help strengthen the company’s OEM business | 28.6 |
2004 | Launch of the multichannel mechanical mLINE pipettes Launch of quick tests for diagnosis of Helicobacter pylori infection and lactose intolerance The US Food and Drug Administration (FDA) approval for the GastroPanel test kit’s serum-based H. pylori test Prize awarded to Biohit by VWR USA, one of the largest global distributors of liquid handling products | 26.7 |
2003 | Launch of the multichannel electronic eLINE pipettors Establishement of Biohit’s representative office in China Further development of the production at the Kajaani plant Diagnostics business receives ISO 13485 certification and CE/IVD compliance | 26.2 |
2002 | Launch of the new mLINE mechanical pipettor range Enlargement of the electronic eLINE pipettor product range Continuation of the automatisation at the production premises in Kajaani Biohit opens a subsidiary in Russia | 25.3 |
2001 | Marketing of the GastroPanel began for research use and several clinical evaluations are being carried out Development of test kit for cellular fibronectin (cFn) Completion of new production premises for diagnostics in Helsinki, Finland Service laboratory operations start. | 25.5 |
2000 | Completion of new production premises in Kajaani Accreditation of Biohit’s pipette calibration laboratory in Finland Preparation to commence the global marketing and sales of diagnostic tests and analyzing systems Commencement of the sales of instruments Reinforcement of international collaboration and customer service organization through acquisitions in the US and Russia | 24.2 |
1999 | Listing on Helsinki Exchanges (New Market list) Continuation of the aggressive patenting policy | 20.5 |
1998 | Assembling of pipettors and injection moulding begins in Helsinki Locus genex Oy and Biohit Systems, Inc. become Biohit Group companies External evaluation of the first test kit (Pepsinogen I) of the GastroPanel program Ph.D. Thesis of Auli Linnala: Basic research on Biohit’s monoclonal antibodies (cFn and tenascin), which are related with cancer diagnostics | 16.8 |
1997 | Moving into new facilities in Helsinki ISO 9001 quality system certification Co-operation with Becton Dickinson and 3M begins Receiving EUREKA[2] status on the basis of which TEKES funding received for the GastroPanel program | 14.4 |
1996 | Reinforcement of international sales and marketing The GastroPanel program begins Ph.D. Thesis of Sari Ylätupa: An application invention of vertical measurement and immunoassays; the determination of cFn from blood samples and its importance in cancer diagnostics | 12.6 |
1995 | Launch of several new liquid handling products Establishment of a Biohit subsidiary in Germany Co-operation with Eastman Kodak Co. Clinical Diagnostic Systems, later acquired by Johnson & Johnson begins | 10.5 |
1994 | Development of the renewed electronic pipettor Co-operation with Ortho Diagnostic Systems of Johnson & Johnson begins Establishment of joint venture in Japan Ph.D. Thesis of Osmo Suovaniemi: The vertical measurement invention, its applications and the invention of electronic liquid handling devices | 8.4 |
1993 | Launch of the multichannel Proline mechanical pipette Co-operation regarding liquid handling products with Eppendorf and bioMérieux begins | 6.4 |
1992 | Launch of the Proline mechanical pipette Launch of the multichannel Proline electronic pipettor Establishment of subsidiaries in Italy and the UK Ph.D. Thesis of Tapani Tiusanen: An application invention of vertical measurement; the self-correcting, multiparameter measuring instrument | 4.2 |
1991 | TEKES funding for the development of mechanical pipettors Establishment of the first Biohit subsidiary, in France Introduction of new monoclonal antibodies | 2.1 |
1990 | Worldwide introduction of the first ergonomically designed electronic pipettor, the Proline Assembling of pipettors and injection moulding begins in Kajaani, Finland Introduction of first monoclonal antibodies | 0.49 |
1989 | TEKES[1] funding received for the electronic and mechanical pipettors, pipettor tips as well as microplates | 0.12 |
1988 | Establishment of Biohit Oy Electonic pipettor development begins Establishment of Locus genex Oy, the current diagnostics division of the Biohit Group |